 Piracetam is a nootropic type drug that has shown many great benefits for various treatments of Senile Dementias including Alzheimer's disease, Attention Deficit Disorder, Down Syndrome and the disease Myoclonus ("myo") muscle ("clonus") jerk which arises from damage to the central nervous system which affects the brain and spinal cord. Piracetam has shown much promise in the prevention of cognitive deficiencies leading to dementias and as a neuro-protective agent preventing damage to the brain from trauma, convulsions and hypoxia. But perhaps one of the most exciting claims of Piracetam is that this drug appears to be virtually non toxic.
Piracetam is perhaps more commonly known as a "smart drug". It has an understandably high demand from seekers of supplemental cognitive enhancers since it is reported to be an intelligence booster and a stimulant to the central nervous system with no addictive properties. Testimonials of this wonderful supplement run into the tens of thousands with the international availability now stretching to over a third of the world’s countries and it has been freely available and prescribed for the last 35 years. It is, at best, peculiar that Piracetam is not sold freely as a health supplement in the US but perhaps this is because it is a drug, which has not yet received FDA approval. What is holding up the FDA approval of Piracetam and the use of such drug, which has reported such remarkable results in so many different medical situations is a question that will remain unanswered until the FDA decides to issue its findings.
 In a recent German article it was shown that Piracetam plays a key role in the process of synaptic transmission by enhancing neuronal stimulation by almost 50 percent. This is even more good news concerning the benefits of Piracetam for those sufferers of Attention Deficit Disorder, Down syndrome and Myoclonus epilepsy. Furthermore, recent data collected from research done at the Children's National Medical Center in Washington, DC showed that clinical drug trials of Piracetam seem to control the seizures and improve the quality of life of the patients suffering from progressive Myoclonus epilepsy. In a 14 month trial with volunteering adolescents using Piracetam continuously resulted in a convincing improvement in the scholastic performance of all 48 volunteers. These students were chosen due to their usual under-performance and under-achievement. Piracetam results were described by its cerebral metabolic effects, increasing cerebral energy function and its additional brain protection. The report concluded that Piracetam performed high selective activity on the cerebral cortex, which is known to be responsible for the higher mental functioning abilities of the brain. There was conclusive improvement in consciousness, vigilance and enhanced memory. Similar results were found when using Piracetam on (so-called) dyslexic students. An additional study was performed in China (1992) in order to evaluate the antioxidant effects of Piracetam. The results revealed that Piracetam had the potential action of scavenging free radicals. This prompted further investigation and in Zurich, Switzerland the effects of a single-dose of Piracetam on 12 healthy young humans was measured. The conclusion was a decreased EEG complexity which was interpreted as a definite improvement of brain functional processes. The list of trials and clinical studies showing positive results on mental function is exhaustive. For those sufferers of ADD/ADHD who have experienced the spaced out effects or jitters from Dexedrine usually find Piracetam a wonderful replacement. People claim to experience the feeling of being focused, alert and energetic, sometimes for the first time in their lives. They can read undistracted and achieve drastically improved results under test conditions. It is no wonder that Piracetam is the world’s best selling nootropic drug (nootropic means acting on the brain) and who couldn’t prosper from ‘waking up their brain’? Approved Uses © IAS Ltd. | 
